Amina Ridoine*, Marielle Morissens and Jose Castro Rodriguez
Immune Checkpoint Inhibitors induced Myocarditis is a serious adverse event. The clinical manifestation can be quite variable and the classic features of myocarditis are not always found. Although challenging, the diagnosis remains necessary in this potentially life-threatening complication. We present the case of a patient treated with nivolumab who developed a late immune checkpoint inhibitor induced myocarditis, without positive diagnostic findings in cardiac magnetic resonance imaging. Early initiation of corticosteroid therapy resulted in good outcome.
HTML PDFShare this article
Journal of Clinical Case Reports received 1345 citations as per Google Scholar report